Type-2 alkenes mediate synaptotoxicity in neurodegenerative diseases.

作者: Richard M. LoPachin , Terrence Gavin , David S. Barber

DOI: 10.1016/J.NEURO.2008.04.016

关键词: Environmental exposureOxidative stressCell biologyLiberationChemistryCarcinogenAcroleinNeuroscienceAlzheimer's diseaseLipid peroxidationSynapse

摘要: Synaptic dysfunction appears to be an early pathogenic event in Alzheimer's disease, amyotrophic lateral sclerosis and Parkinson's disease. Although the molecular mechanism of this synaptotoxicity is not known, evidence suggests that these diseases are characterized by a common pathophysiological cascade involving oxidative stress, lipid peroxidation subsequent liberation α,β-unsaturated carbonyl derivatives such as acrolein 4-hydroxy-2-nonenal (HNE). A diverse body vivo vitro data have shown soft electrophilic chemicals can cause nerve terminal damage forming Michael-type adducts with nucleophilic sulfhydryl groups on presynaptic proteins. Therefore, endogenous generation HNE oxidatively stressed neurons certain brain regions might mechanistically related associated neurodegenerative conditions. In addition, members large class structurally known type-2 alkenes. Chemicals (e.g., acrylamide, methylvinyl ketone, methyl acrylate) pervasive pollutants human environments new research has also toxic terminals. review, we provide regional synaptotoxicity, which develops during stages many diseases, mediated HNE. Based presumed site action, propose onset progression neuropathogenic process accelerated environmental exposure other

参考文章(204)
E Masliah, M Alford, R D Terry, R DeTeresa, L A Hansen, Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease. American Journal of Pathology. ,vol. 138, pp. 235- 246 ,(1991)
A. J. McComas, P. B. Jorgensen, A. R. M. Upton, The neurapraxic lesion: a clinical contribution to the study of trophic mechanisms. Canadian Journal of Neurological Sciences. ,vol. 1, pp. 170- 179 ,(1974) , 10.1017/S0317167100119213
Rocco Di Paola, Ryan J. Uitti, Early Detection of Parkinson??s Disease Drugs & Aging. ,vol. 9, pp. 159- 168 ,(1996) , 10.2165/00002512-199609030-00002
K. S. Montine, T. J. Montine, D. G. Graham, V. Amarnath, W. O. Whetsell, S. J. Olson, Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4. American Journal of Pathology. ,vol. 150, pp. 437- 443 ,(1997)
Jonathan S. Stamler, Santiago Lamas, Ferric C. Fang, Nitrosylation. the prototypic redox-based signaling mechanism. Cell. ,vol. 106, pp. 675- 683 ,(2001) , 10.1016/S0092-8674(01)00495-0
Noel Y. Calingasan, Koji Uchida, Gary E. Gibson, Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease. Journal of Neurochemistry. ,vol. 72, pp. 751- 756 ,(1999) , 10.1046/J.1471-4159.1999.0720751.X
Inna Kruman, Annadora J. Bruce-Keller, Dale Bredesen, Georg Waeg, Mark P. Mattson, Evidence that 4-Hydroxynonenal Mediates Oxidative Stress-Induced Neuronal Apoptosis The Journal of Neuroscience. ,vol. 17, pp. 5089- 5100 ,(1997) , 10.1523/JNEUROSCI.17-13-05089.1997
Ruth G. Perez, Teresa G. Hastings, Could a loss of α‐synuclein function put dopaminergic neurons at risk? Journal of Neurochemistry. ,vol. 89, pp. 1318- 1324 ,(2004) , 10.1111/J.1471-4159.2004.02423.X